Chief Executive Officer
Current
Mar 2024 - Present
AeroLeads people directory · profile
Sam Osman Email & Phone Number
CEO, Endpoint Clinical | Group CEO, Neovance
at
Endpoint Clinical
1 work email found
@scienceandmedicinegroup.com
4 phones found area 813, 913, and 919
LinkedIn matched
4 data sources
Profile completeness 100%
Current company
Role
CEO, Endpoint Clinical | Group CEO, Neovance
Location
Raleigh, North Carolina, United States
Who is Sam Osman? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Sam Osman is listed as CEO, Endpoint Clinical | Group CEO, Neovance at Endpoint Clinical, based in Raleigh, North Carolina, United States. AeroLeads shows a work email signal at scienceandmedicinegroup.com, phone signal with area code 813, 913, 919, and a matched LinkedIn profile for Sam Osman.
Sam Osman previously worked as Chief Executive Officer at Endpoint Clinical and Group Chief Executive Officer at Neovance. Sam Osman holds Executive Education, Finance And Financial Management Services from The Wharton School.
Company email context
Email format at Endpoint Clinical
This section adds company-level context without repeating Sam Osman's masked contact details.
{first}.{last}@scienceandmedicinegroup.com
86% confidence
AeroLeads found 1 current-domain work email signal for Sam Osman. Compare company email patterns before reaching out.
Profile bio
About Sam Osman
Track record of successful product launches and turnarounds of companies/business units. Successfully enabling sales growth and operational delivery Technology and Life SciencesMultiple new technology product launches leading to >$50M growth in under 36 months. Experience in restructuring of international operations units to drive quality improvements and margin expansionRevenue & Customer Management at various deal sizes $10M to $350M+Global leadership, including virtual and cross-cultural teams across APAC, Europe, The Americas. People management – restructured entire management teams; replaced with blend of internal/external resourced to build high performance global leadership teams Lifescience knowledge includes: end to end clinical trials, eClinical technologies, med-tech, pharma services
Listed skills include Strategy, Finance, Financial Analysis, Investments, and 16 others.
Current workplace
Sam Osman's current company
Company context helps verify the profile and gives searchers a useful next step.
15 roles · 20 years
Sam Osman work experience
A career timeline built from the work history available for this profile.
Group Chief Executive Officer
Current
Mar 2024 - Present
President, Enabling Services
CurrentC-Suite executive leading an independently reported P&L for a public company comprised of technologies and services spanning the clinical and commercial markets. Member of the founding team that spun-out the business from LabCorp(LH) and successfully IPO'd (FTRE)
May 2023 - Present
Board Of Directors
Recapitalized by LifeArc and DDF in December 2023Digital Biomarker technology focusing on Neurology diseases through use of physical headset and validated instruments together providing an earlier and more accurate predictor of Neurological disease
2020 - Dec 2023
Board Of Directors
Acquired by Grant Avenue Capital. CREO is a fast growing consultancy serving the life sciences, healthcare and private equity markets. Started by two incredible co-founders that I was fortunate enough to interact with and watch their methodical focus which led to a successful exit.
2019 - Sep 2023
Board Of Directors
2020 - May 2023
Chief Executive Officer
PE Backed conglomerate in the life sciences space. Science & Medicine Group owns several brands including BioInformatics, Kalorama Information, Strategic Directions International, IMV, AuntMinnie, DrBicuspid and several others. S&MG works with Fortune 100 life sciences and pharma companies across strategy planning, launch planning, data insights, market.
2020 - May 2023
Board Of Directors
2020 - 2023
~3 yrs
Venture Partner
Advisor to existing pharma services efforts and in parallel sourcing, diligencing and evaluating new investment opportunities.
2020 - 2023
~3 yrs
Chief Executive Officer
Sold to IQVIA (IQV: NYSE) in Dec 2019Turnaround of IRT business into one of the leading eClinical businesses.Launched eCOA and patient management products
2016 - 2020
~4 yrs
Head Of Connected Devices
Built mobile and connected wearables business incorporating the use of sensor technology within clinical trials. Launch of new technology/service lines. Structured agreements with major medical device OEMs >250 person team
2014 - 2016
~2 yrs
Business Operations - Data Sciences, Safety, Regulatory
2014 - 2016
~2 yrs
Senior Director - Corporate Development & Special Projects
2010 - 2014
~4 yrs
Investment Banking
Consumer Retail and Healthcare industriesNotable transactions include LBO, SPAC, M&A, equity and debt underwriting
2007 - 2010
~3 yrs
Venture Associate
Mutual Capital Partners
Regional VC firm focused on early/ mid stage opportunities. Sourcing, analysis, structuring & execution across single fund portfolio. Co-led two portfolio investments with 1 successful exit ~ 10x Cash on Cash return.
2006 - 2008
~2 yrs
4 education records
Sam Osman education
Executive Education, Finance And Financial Management Services
The Wharton School
Mba
Carnegie Mellon University
Education record
The London School Of Economics And Political Science (Lse)
B.S., International Business, Biology
University Of Tampa
FAQ
Frequently asked questions about Sam Osman
Quick answers generated from the profile data available on this page.
What company does Sam Osman work for?
Sam Osman works for Endpoint Clinical.
What is Sam Osman's role at Endpoint Clinical?
Sam Osman is listed as CEO, Endpoint Clinical | Group CEO, Neovance at Endpoint Clinical.
What is Sam Osman's email address?
AeroLeads has found 1 work email signal at @scienceandmedicinegroup.com for Sam Osman at Endpoint Clinical.
What is Sam Osman's phone number?
AeroLeads has found 4 phone signal(s) with area code 813, 913, 919 for Sam Osman at Endpoint Clinical.
Where is Sam Osman based?
Sam Osman is based in Raleigh, North Carolina, United States while working with Endpoint Clinical.
What companies has Sam Osman worked for?
Sam Osman has worked for Endpoint Clinical, Neovance, Fortrea, Cumulus Neuroscience, and Creo, Inc..
How can I contact Sam Osman?
You can use AeroLeads to view verified contact signals for Sam Osman at Endpoint Clinical, including work email, phone, and LinkedIn data when available.
What schools did Sam Osman attend?
Sam Osman holds Executive Education, Finance And Financial Management Services from The Wharton School.
What skills is Sam Osman known for?
Sam Osman is listed with skills including Strategy, Finance, Financial Analysis, Investments, Financial Modeling, Strategic Partnerships, Investment Banking, and Venture Capital.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial